SCHEMBL2499348

SCHEMBL2499348

O=C1Nc2ccc(Cl)cc2C1(O)c1ccccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.47
TP53 P04637 1/20 0.43
GAA P10253 2/20 0.43
MGAM O43451 1/20 0.43
HTR1A P08908 1/20 0.43
SI P14410 1/20 0.43
HTR2A P28223 1/20 0.43
HTR7 P34969 1/20 0.43
HTR6 P50406 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
BRD4 O60885 2/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
CBX7 O95931 2/20 0.40
CDYL Q9Y232 2/20 0.40
MAPT P10636 2/20 0.40
CDYL2 Q8N8U2 1/20 0.40
CDY1; CDY1B Q9Y6F8 1/20 0.40
SNRNP200 O75643 1/20 0.39
GSK3B P49841 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29143002 0.83 GAA (0.55) TP53GAAMGAMSIMGAM2
SCHEMBL29143018 0.83 TP53 (0.62) TP53GAAMGAMSIMGAM2
SCHEMBL30725601 0.83 TP53 (0.62) TP53GAAMGAMSIMGAM2
SCHEMBL30725543 0.82 KMT2A (0.58) IDO1TP53GAAKMT2AMEN1
SCHEMBL24281107 0.82 KMT2A (0.58) IDO1TP53GAAKMT2AMEN1
SCHEMBL2497407 0.80 BRD4 (0.52) IDO1GAAMGAMHTR1ASI
SCHEMBL29143012 0.79 KMT2A (0.51) IDO1BRD4KMT2AMEN1GSK3B
SCHEMBL1464958 0.77 KMT2A (0.46) IDO1BRD4KMT2AMEN1CBX7
SCHEMBL1465397 0.76 KMT2A (0.48) IDO1BRD4KMT2AMEN1CBX7
SCHEMBL2499637 0.76 POLB (0.51) IDO1GAAMGAMHTR1ASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 IDO1 4/4885TP53 470/4885GAA 3124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.